Evolution Principal Jim Cummings shares his insights and expertise on the current and future state of the Neurology market in November’s edition of Medical Marketing & Media (MM&M).

New therapies are shaking up MS and insomnia, while the slow pace of progress in Alzheimer’s continues to frustrate patients and physicians alike. Welcome to neurology, where, Joe Dysart reports, treatment breakthroughs in certain areas are counteracted by setbacks in others.

Therapeutic Focus 2014: Neurology is available on the MM&M website.